BIIB 131.57 -0.09 / Biogen Idec, Inc. FDA | Benzinga

Wednesday, May 09, 2012

Biogen Idec Announces US and EU Regulatory Authorities Accept Oral BG-12 Marketing Applications for Review (BIIB, News, FDA / Wed, 04:08pm)

Tuesday, April 24, 2012

Biogen Idec Announces Positive Results from Phase 3 CONFIRM Clinical Trial Show Efficacy and Safety of Oral BG-12 in Multiple Sclerosis (BIIB, News, FDA / Tue, 07:33am)

Wednesday, April 04, 2012

Financial Breakfast: Morning News Summary for April 4, 2012 (BIIB, Bonds, DDIC, MCD, MDCA, News, SBUX, THI, VIAS, Futures, Guidance, Upgrades, Downgrades, Forex, Technicals, FDA, M&A, Events, Global, Econ #s, Economics, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas, General / Wed, 07:24am)

Wednesday, March 14, 2012

Biogen Idec Takes Option to MAKScientific MS Program (BIIB, News, FDA / Wed, 10:19am)

Thursday, March 08, 2012

Biogen Idec Spokesperson Refutes Claims of Biopharm Insight Article (BIIB, News, Rumors, FDA, Movers, General / Thu, 03:24pm)

Tuesday, February 28, 2012

Biogen Idec Submits Application to FDA for Approval of Oral BG-12 to Treat Multiple Sclerosis (BIIB, News, FDA / Tue, 09:02am)
Biogen Idec Announces FDA Approves AVONEX PEN and Dose Titration Regimen (BIIB, News, FDA / Tue, 08:33am)
Samsung Biologics and Biogen Idec Announce Formation of Biosimilars Joint Venture Samsung Bioepis (BIIB, News, Contracts, FDA / Tue, 08:17am)

Thursday, January 26, 2012

From Earlier: Biogen Idec and Elan Corporation Announce ASCEND Study to Evaluate the Effectiveness of TYSABRI as a Treatment for Secondary-Progressive Multiple Sclerosis (BIIB, ELN, MS, News, RRMS, FDA / Thu, 09:53am)

Friday, January 20, 2012

Quest Diagnostics STRATIFY JCV First FDA Market Authorized Antibody-based Blood Test to Help Stratify PML Risk in Multiple Sclerosis Patients (BIIB, DGX, ELN, News, FDA / Fri, 05:00pm)
Deutsche Bank Maintains Buy on Biogen Idec After European Medical Agency Announcement (Analyst Color, BIIB, News, Reiteration, FDA, Global, Pre-Market Outlook, Analyst Ratings / Fri, 08:11am)

Monday, January 09, 2012

Just What The Doctor Ordered: 4 ETFs For Biotech M&A (ACHN, AFFX, ALXN, AMGN, BBH, BIIB, BMRN, BMY, CELG, DNDN, FBT, GILD, IDIX, INHX, ITMN, Long Ideas, News, PSCH, REGN, Sector ETFs, XBI, Short Ideas, Specialty ETFs, New ETFs, Rumors, Small Cap Analysis, Technicals, FDA, M&A, Events, Intraday Update, After-Hours Center, Markets, Movers, Trading Ideas, ETFs / Mon, 04:49pm)

Wednesday, January 04, 2012

Biogen Idec and Isis Pharmaceuticals Announce Global Collaboration for Antisense Program Targeting Spinal Muscular Atrophy (BIIB, ISIS, News, SMA, FDA / Wed, 09:31am)

Tuesday, December 20, 2011

Deutsche Bank Reiterates Buy, $129 PT On Biogen Idec (Analyst Color, BIIB, News, Price Target, Reiteration, FDA, Intraday Update, Markets, Analyst Ratings, Trading Ideas / Tue, 12:18pm)

Tuesday, December 06, 2011

J.P. Morgan Reiterates Neutral On Biogen Idec (Analyst Color, BIIB, News, Reiteration, FDA, Intraday Update, Markets, Analyst Ratings, Trading Ideas / Tue, 02:28pm)

Thursday, October 27, 2011

Biogen Idec and Portola Pharmaceuticals Announce Global Collaboration for Oral Syk Inhibitor Program Targeting Autoimmune and Inflammatory Diseases (BIIB, News, Contracts, FDA / Thu, 08:35am)

Wednesday, October 26, 2011

Biogen Idec Announces Positive Top-Line Results from Second Phase 3 Trial Investigating Oral BG-12 in Multiple Sclerosis (BIIB, News, FDA / Wed, 07:00am)

Thursday, October 20, 2011

From Earlier, Biogen Idec and Elan Receive Notification of PDUFA Date Extension (BIIB, ELN, News, FDA / Thu, 08:56am)

Wednesday, October 19, 2011

Biogen Idec and Elan Announce Data about Early Use and Long-Term Benefit of TYSABRI Presented at 5th Joint Triennial Congress of ECTRIMS and ACTRIMS (BIIB, ELN, News, FDA / Wed, 06:23am)

Tuesday, August 09, 2011

Biogen Idec and Abbott Announce Positive Top-Line Results from the First Registrational Trial for Daclizumab HYP in Relapsing-Remitting Multiple Sclerosis (ABT, BIIB, News, FDA / Tue, 08:01am)

Monday, July 25, 2011

Biogen Idec Receives Conditional Approval in the European Union for FAMPYRA® to Improve Walking in Adults with Multiple Sclerosis (BIIB, MS, News, FDA / Mon, 09:13am)

Monday, June 06, 2011

Biogen Idec Reports Positive Data from AVONEX Dose Titraion Study at 2011 Annual Meeting of the Consortium of Multiple Sclerosis Centers (BIIB, News, FDA / Mon, 07:30am)

Thursday, March 31, 2011

Biogen Idec Enrolls In Global Phase III Study of Dexpramipexole (BIIB) (BIIB, News, SPA, FDA / Thu, 08:35am)
Biogen Idec and Knopp Biosciences Announce Enrollment of the First Patient in a Global Phase III Study of Dexpramipexole for ALS (BIIB) (BIIB, FDA / Thu, 08:31am)

Tuesday, February 01, 2011

A Peek Into The Market Before The Trading Starts (Analyst Color, BIIB, CE, CKP, Earnings, News, OREX, XOM, Futures, Price Target, FDA, M&A, Pre-Market Outlook, Intraday Update, Markets, Analyst Ratings, Trading Ideas / Tue, 08:58am)

Friday, January 28, 2011

FDA Approves Rituxan for First-Line Maintenance Use in Follicular Lymphoma (BIIB, News, FDA, Events / Fri, 04:39pm)

Friday, January 21, 2011

Biogen Idec Receives Negative Opinion on FAMPYRA in Europe (BIIB, News, FDA / Fri, 08:36am)

Wednesday, September 22, 2010

Biogen Falling On Novartis Approval (BIIB, News, NVS, FDA, Movers / Wed, 11:52am)

Tuesday, September 07, 2010

Momenta Loses Generic Copaxon Bid (MNTA, TEVA, BIIB) (BIIB, MNTA, FDA, Movers / Tue, 11:20am)

Tuesday, July 20, 2010

Biogen TYSABRI Patient Growth (BIIB, News, FDA, Markets / Tue, 07:28am)

Monday, March 08, 2010

Roche And Biogen Idec (BIIB) Suspend Rheumatoid Arthritis Drug Program (BIIB, News, FDA, Global, Markets / Mon, 09:07am)

Tuesday, January 19, 2010

Biogen Idec’s (BIIB) Business Strategy To Maximize Shareholder Value (Analyst Color, BIIB, News, Price Target, Initiation, FDA, Markets, Analyst Ratings / Tue, 09:30am)

Tuesday, January 12, 2010

Biogen Idec Inc. (BIIB) Submits Application For Approval Of Fampridine-PR Tablets In Europe (BIIB, JPM, MAA, News, FDA, Markets / Tue, 11:28am)

Thursday, January 07, 2010

Patients Develop Infection Using Tysabri, (BIIB) (BIIB, News, FDA, Markets / Thu, 11:14am)

Wednesday, January 06, 2010

Celgene’s (CELG) 2010 Guidance To Set The Trend (AMGN, BIIB, CELG, GILD, JPM, News, Guidance, FDA, Markets / Wed, 12:22pm)

Thursday, October 29, 2009

FDA Confirms 24 total PML Cases Since Tysabri Re-Launched (BIIB, ELN, News, FDA / Thu, 12:31pm)